| 1 | Albuterol nebulizer | 1件: Salbutamol Salbutamol | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 89 89 |
| 2 | Bramitob® administered by PARI eFlow® rapid electronic nebulizer | - | - | - | - | 1件: 299 299 |
| 3 | Bramitob® administered by PARI LC® PLUS nebulizer | - | - | - | - | 1件: 299 299 |
| 4 | Breelib nebulizer | - | - | - | - | 1件: 86 86 |
| 5 | Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. | 1件: Amikacin Amikacin | 2件: D00865
D00865
,
D02543
| - | - | 1件: 299 299 |
| 6 | Molgramostim 300 µg nebulizer solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
| 7 | Molgramostim nebulizer solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 299 299 |
| 8 | Nebulizer | - | - | - | - | 1件: 6 6 |
| 9 | PARI eFlow nebulizer system | - | - | - | - | 1件: 299 299 |
| 10 | Tobramycin inhalation solution using a PARI LC® Plus nebulizer. | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
| 11 | Treprostinil Ultrasonic Nebulizer | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 85 85 |